Immunohematology and Transfusion Medicine
Immunohematology and transfusion medicine is the branch of clinical laboratory science concerned with the antigens carried on blood cells, the antibodies directed against them, and the safe selection, preparation, and administration of blood components. It joins serologic and molecular testing of donor and recipient blood with the clinical practice of transfusion, so that a unit of blood reaching a patient is immunologically compatible and the risks of an adverse reaction are minimised.
Definition
Immunohematology is the study of red-cell, platelet, and granulocyte antigens and the antibodies they provoke; transfusion medicine applies this knowledge to the collection, testing, storage, and clinical use of blood and blood components.
Scope
This area orients the reader to four essentials handled in detail by its topics: the blood group systems and how their antigens are detected; the identification of antibodies and the compatibility (crossmatch) testing that precedes transfusion; the reactions and adverse events that may follow transfusion; and the rationale for blood component therapy. It is a reference and educational overview of how the discipline is organised, not a procedural manual or a source of dosing instructions.
Sub-topics
Core questions
- Which antigens does a patient's red cells carry, and which antibodies does their plasma contain?
- Is a given donor unit immunologically compatible with a given recipient?
- Which blood component, if any, addresses the patient's deficit, and what evidence supports its use?
- How are transfusion reactions recognised, classified, and prevented?
Key concepts
- Blood group antigens and systems
- ABO and RhD typing
- Alloantibodies and autoantibodies
- Antiglobulin (Coombs) testing
- Antibody screen and identification panel
- Crossmatch and compatibility testing
- Blood components (red cells, platelets, plasma, cryoprecipitate)
- Restrictive versus liberal transfusion thresholds
- Haemovigilance and transfusion reactions
Mechanisms
The discipline rests on antigen-antibody recognition. Red-cell membranes carry inherited carbohydrate and protein antigens grouped into systems such as ABO and Rh; exposure to non-self antigens through transfusion or pregnancy can stimulate alloantibodies, while autoantibodies may form against self antigens. Laboratory testing detects these antigens and antibodies serologically — including by the antiglobulin test, which reveals antibody bound to red cells — and increasingly by molecular genotyping. Compatibility testing then matches donor units to a recipient so that pre-formed antibodies do not encounter their target antigen in vivo, where binding could trigger complement-mediated or extravascular haemolysis (Panch et al., 2019; Storry et al., 2013).
Clinical relevance
The work of this area underlies the safety of every transfusion: typing, antibody detection, and compatibility testing determine which units may be issued, and contemporary guidelines frame when transfusion is indicated at all. As a reference field it explains how blood is tested and matched and how the evidence behind transfusion practice is generated; it is not a substitute for the judgement of treating clinicians and provides no individualised treatment or dosing advice (Carson et al., 2017; Carson et al., 2023).
Epidemiology
Blood transfusion is among the most common procedures in hospital medicine, and red cells are the most frequently transfused component worldwide. Large clinical trials and the resulting AABB international guidelines have shifted practice toward more restrictive haemoglobin thresholds in many stable patient groups, reducing exposure to allogeneic blood (Carson et al., 2017; Carson et al., 2023).
History
The field opened with Karl Landsteiner's recognition of the ABO blood groups at the turn of the twentieth century, which made compatible transfusion conceivable. The mid-century introduction of the antiglobulin (Coombs) test allowed detection of clinically important antibodies that do not directly agglutinate red cells, and the discovery of the Rh system clarified haemolytic disease of the fetus and newborn. Standardised nomenclature for blood group systems and alleles, and evidence-based transfusion guidelines, have since professionalised both the laboratory and clinical sides of the discipline (Storry et al., 2013; Carson et al., 2023).
Key figures
- Karl Landsteiner
- Robin Coombs
- Jeffrey Carson
- Harvey Klein
Related topics
Seminal works
- storry-2013
- carson-2017
- carson-2023
Frequently asked questions
- What is the difference between immunohematology and transfusion medicine?
- Immunohematology is the laboratory science of blood-cell antigens and the antibodies against them; transfusion medicine is the clinical application of that knowledge to the safe selection and administration of blood components. In practice the two are taught and practised together.
- Why must blood be tested before transfusion?
- Recipients may carry pre-formed antibodies, from prior transfusion or pregnancy, that react with antigens on donor red cells. Typing, antibody screening, and compatibility testing identify these so that incompatible units are not issued and haemolytic reactions are avoided.